EXPLORINEER
en

Archive — US — techcrunch

Heidi Health raises $65M Series B led by Steve Cohen’s Point72

Heidi Health has raised $65 million in a Series B funding round led by Point72, aiming to alleviate administrative burdens on healthcare providers with its AI medical scribe. Founded by Dr. Tom Kelly in 2021, the company has returned over 18 million hours to clinicians and works with millions weekly, promoting increased clinical capacity, especially in underserved areas. Heidi Health's mission is to enhance healthcare delivery through AI.

Key points

  • Heidi Health, founded by Dr. Tom Kelly and Waleed Mussa in 2021, focuses on AI solutions for healthcare to reduce administrative tasks.
  • The company raised $65 million in Series B funding to advance product development and improve user experience.
  • Heidi Health claims to have saved over 18 million hours for healthcare providers from 70 million patient visits across 116 countries.
  • The AI medical scribe transcribes notes, generates patient summaries, and tracks tasks, enhancing workflow for clinicians.
  • Dr. Simon Kos and Paul Williamson are among new key personnel joining the team post-funding.
  • Heidi Health's approach is agnostic to AI models, optimizing accuracy and cost efficiency.
  • The company aims to expand healthcare access in challenging regions, emphasizing the role of AI in transforming healthcare delivery.

Why it matters

  • The funding aligns with the 2025 IT trend of increasing investment in healthcare technology, particularly in AI capabilities for professionals.
  • Historically, similar healthcare startups have emerged, yet Heidi Health differentiates itself by focusing on user experience and direct clinician benefits.
  • The move towards AI-driven healthcare solutions reflects a broader industry shift toward automation and efficiency in medical practices.

Heidi Health's significant funding marks a pivotal step in revolutionizing healthcare with AI, aiming to streamline the work of providers and enhance patient care, especially in underserved regions. The investment sets a precedent for technology's role in both optimizing clinical workflows and expanding healthcare access globally.